Why Privacy Changes Demand a Better Approach to Targeting: Real World Data
By: [email protected], Content Manager, Swoop
Building custom audience segments can help marketers better reach consumers.
[email protected], SVP of sales at Swoop, explains how pharma brands can leverage condition-specific patient segments to connect with more relevant consumer audiences online. Carr delves into the privacy changes being made by branded technology walled gardens and why strengthening targeting via a custom-built patient audience segment puts advertisers in a more favorable position as those shifts occur.
About the Author
[email protected]
Content Manager
| |
|
Emilie has nearly a decade of experience in marketing, writing, research and strategy for the pharmaceutical industry. She has contributed to top pharmaceutical publications including American Pharmaceutical Review, European Pharmaceutical Review, Pharmaceutical Manufacturing, Manufacturing Chemist, Pharmaceutical Outsourcing, Specialty Chemicals, and Contract Pharma. Prior to joining Swoop/IPM.ai, Emilie served as Strategic Content Manager and Managing Editor for Pharma’s Almanac where she lent her voice to some of the industry’s top players including GSK, MilliporeSigma and ThermoFisher Scientific.
|
Swoop
Transforming Omnichannel
Swoop is a market leader in privacy-safe, award-winning omnichannel healthcare marketing solutions. Our platform connects patients, HCPs, and brands at scale across all channels, delivering unmatched engagement and proximity to patients throughout their health journey. By combining AI-driven technology with real-world data (RWD), first- and zero-party data, and engagement data, Swoop empowers pharma marketers to make faster, more precise decisions that improve patient outcomes.
